| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 12/20/2012 | WO2005046607A3 Combinations for the treatment of proliferative diseases |
| 12/20/2012 | US20120324593 Lysyl Oxidase-Like 1 (LOXL1) and Elastogenesis |
| 12/20/2012 | US20120322865 Sustained polypeptide expression from synthetic, modified rnas and uses thereof |
| 12/20/2012 | US20120322864 Sustained polypeptide expression from synthetic, modified rnas and uses thereof |
| 12/20/2012 | US20120322850 Trpm-2 antisense therapy |
| 12/20/2012 | US20120322689 Use of meganucleases for inducing homologous recombination ex vivo and in toto in vertebrate somatic tissues and application thereof |
| 12/20/2012 | US20120322674 Detecting cyp24 expression level as a marker for predisposition to cancer |
| 12/20/2012 | US20120322105 Growth factor |
| 12/20/2012 | US20120321696 Accelerating Thrombus Resolution Through Augmentation of p53 Activity |
| 12/20/2012 | US20120321662 Methods of Eliciting or Boosting a Cellular Immune Response |
| 12/20/2012 | US20120321651 Anti-IGE Vaccines |
| 12/20/2012 | US20120321639 Methods and compositions for the inhibition of stat5 in prostate cancer cells |
| 12/20/2012 | US20120321614 Antibodies to c-met |
| 12/20/2012 | US20120321599 Herpes virus strains |
| 12/20/2012 | US20120321598 Vectors and methods for long-term immune evasion to prolong tranplant viability |
| 12/20/2012 | US20120321594 Methods of controlling axon or dendrite development of neuronal cells |
| 12/20/2012 | US20120321552 Compositions and Methods for Identifying and Targeting Cancer Cells of Alimentary Canal Origin |
| 12/19/2012 | EP2535412A1 New treatment for muscular dystrophies |
| 12/19/2012 | EP2535406A1 Meganuclease variants cleaving a DNA target sequence from the human hemoglobin beta gene and uses thereof |
| 12/19/2012 | CN102827875A Recombinant adenovirus for expressing mouse nerve growth factors and preparation method thereof |
| 12/19/2012 | CN102827864A Recombinant bacillus subtilis CoxA16-VP1 expression vector as well as preparation method and application thereof |
| 12/19/2012 | CN102827843A Orail gene-oriented short hairpin ribonucleic acid (shRNA) for inhibiting tumor proliferation and metastasis, and application thereof |
| 12/19/2012 | CN102827841A Inhibition of viral gene expression using small interfering RNA |
| 12/19/2012 | CN102827840A SiRNA inhibiting PPFIA1 gene expression, and its application |
| 12/19/2012 | CN102827267A Humanized pika leptin protein, gene coding same and application thereof |
| 12/19/2012 | CN102827265A Novel gene of sorting nexin (SNX) family and use thereof |
| 12/19/2012 | CN102827251A Transmembrane peptide-mediated antisense antibacterial agent and preparation method and application thereof |
| 12/19/2012 | CN102824647A Bone-targeted delivery system for osteogenesis treatment based on small nucleic acid medicine, and preparation method thereof |
| 12/19/2012 | CN102824637A Application of TRPC5 as drug target in reversing multi-drug resistance |
| 12/19/2012 | CN102824634A Recombined Swinepox virus carrier vaccine capable of expressing porcine circovirus 2-type Cap protein and preparation method thereof |
| 12/19/2012 | CN102824306A Folic acid modified chitosan coated plasmid nanoparticles and preparation method thereof |
| 12/19/2012 | CN102188719B Application of EB virus miR-BART3 antisense oligonucleotides in preparing medicament for treating nasopharyngeal darcinoma |
| 12/19/2012 | CN102174518B Main cis-acting element of shrimp white spot syndrome virus (WSSV) iel promoter and transcription factor combined with same and application |
| 12/19/2012 | CN102115787B MicroRNA (Ribose Nucleic Acid) and application of antisensenucleic acid of microRNA in diagnosis, prevention, treatment and/or prognostic evaluation of heart disease |
| 12/19/2012 | CN102038959B Application of let-7/miR-98 family in preparation of medicament for treating disease related to FAS (Fatty Acid Synthase) gene |
| 12/19/2012 | CN102021175B Optimized grass carp alpha interferon encoding gene and application thereof |
| 12/19/2012 | CN101972476B DNA vaccine adjuvant using Micro RNA-155 and construction method thereof |
| 12/18/2012 | US8334373 Nuclease resistant double-stranded ribonucleic acid |
| 12/18/2012 | US8334370 Polynucleotides comprising intercalating entities |
| 12/18/2012 | US8334275 Cellular genes regulated by HIV-1 infection and methods of use thereof |
| 12/18/2012 | US8334271 Use of VEGF in the treatment of retarded fetal growth in pregnancy |
| 12/18/2012 | CA2472163C Psoriasin expression by breast epithelial cells |
| 12/18/2012 | CA2460468C Novel polypeptide, dna thereof and use of the same |
| 12/18/2012 | CA2451173C Vector encoding human globlin gene and use thereof in treatment of hemoglobinopathies |
| 12/18/2012 | CA2398064C 84p2a9: a prostate and testis specific protein highly expressed in prostate cancer |
| 12/18/2012 | CA2385122C Mutated anthrax toxin protective antigen proteins that specifically target cells containing high amounts of cell-surface metalloproteinases or plasminogen activator receptors |
| 12/18/2012 | CA2363486C Compositions and methods for effecting the levels of high density lipoprotein (hdl) cholesterol and apolipoprotein ai, very low density lipoprotein (vldl) cholesterol and low density lipoprotein (ldl) cholesterol |
| 12/13/2012 | WO2012171024A2 Enzyme directed assembly of particle theranostics |
| 12/13/2012 | WO2012170977A1 Modulation of pancreatic beta cell proliferation |
| 12/13/2012 | WO2012170957A2 Retinoid-liposomes for enhancing modulation of hsp47 expression |
| 12/13/2012 | WO2012170947A2 Methods for modulating factor 12 expression |
| 12/13/2012 | WO2012170945A2 Methods for modulating kallikrein (klkb1) expression |
| 12/13/2012 | WO2012170776A2 Methods of determining a patient's prognosis for recurrence of prostate cancer and/or determining a course of treatment for prostate cancer following a radical prostatectomy |
| 12/13/2012 | WO2012170742A2 Treatment and prevention of cancer with hmgb1 antagonists |
| 12/13/2012 | WO2012170664A2 Methods of cancer treatment and prevention through the modulation of sirt4 activity |
| 12/13/2012 | WO2012170250A1 Morpholino oligonucleotides capable of inhibiting cd47-mediated cellular damage and uses thereof |
| 12/13/2012 | WO2012170125A2 Algal produced malarial transmission blocking vaccines |
| 12/13/2012 | WO2012168259A1 Protein tyrosine phosphatase, non-receptor type 11 (ptpn11) and triple-negative breast cancer |
| 12/13/2012 | WO2012065059A3 Treatment of atherosclerosis with bmp-alk3 antagonists |
| 12/13/2012 | US20120317664 Use of meganucleases for inducing homologous recombination ex vivo and in toto in vertebrate somatic tissues and application thereof |
| 12/13/2012 | US20120316226 Methods of gene therapy for treating disorders of the ear by administering a vector encoding an atonal-associated factor |
| 12/13/2012 | US20120316220 Methods and compositions for treating insects |
| 12/13/2012 | US20120316112 Rescue of photoreceptors by intravitreal administration of an expression vector encoding a therapeutic protein |
| 12/13/2012 | US20120315634 Distinguishing pca3 messenger rna species in benign and malignant prostate tissues |
| 12/13/2012 | US20120315631 Tumor suppressor designated ts10q23.3 |
| 12/13/2012 | US20120315322 Nanoparticle mediated gene therapy and therapeutic products for alzheimers |
| 12/13/2012 | DE102011103438A1 Use of first generation viologen dendrimers or second or higher generation viologen dendrimers for in vitro transporting oligo-nucleotides, ribonucleic acids and single- or double-stranded DNA into eukaryotic cells |
| 12/12/2012 | EP2532746A2 Bacterially-derived, intact minicells that encompass plasmid-free functional nucleic acid for in vivo delivery to mammalian cells |
| 12/12/2012 | EP2532681A1 Anti-ILT7 antibody |
| 12/12/2012 | EP2531616A1 Diagnostic and prognostic assay for breast cancer |
| 12/12/2012 | EP2531604A2 Compositions and methods for enhanced parvovirus transduction |
| 12/12/2012 | EP2531224A2 Compositions and methods relating to argininosuccinate synthetase |
| 12/12/2012 | CN102822342A Treatment of pancreatic developmental gene related diseases by inhibition of natural antisense transcript to a pancreatic developmental gene |
| 12/12/2012 | CN102816856A Application of DIAPH3 gene and expression product thereof |
| 12/12/2012 | CN102816793A Single carrier bidirectionally started Tet-on inducible expression system, its construction method and application |
| 12/12/2012 | CN102816792A Method for regulating expression, quantity and activity of heat shock protein 70 and application thereof |
| 12/12/2012 | CN102816779A Novel tuberculosis vaccine and combined vaccine thereof |
| 12/12/2012 | CN102816743A Human ubiquitin ligase E3 for the modulation of NF-Kappa B |
| 12/12/2012 | CN102816742A Chimeric adenoviruses for use in cancer treatment |
| 12/12/2012 | CN102816738A Dermal micro-organs, methods and apparatuses for producing and using the same |
| 12/12/2012 | CN102816205A Beta-profilin 1, and fragment and applications thereof |
| 12/12/2012 | CN102813942A Lipid ultrasound microbubble mediated adeno-associated virus gene transfection preparation and preparation technology thereof |
| 12/12/2012 | CN102813941A Application of growth factor gene drug in preventing and treating stress-related gastrointestinal injury |
| 12/12/2012 | CN102813940A Microrna as a cancer progression predictor and its use for treating cancer |
| 12/12/2012 | CN102813939A Gene-viro-therapy medicine specific for prostate cancer |
| 12/12/2012 | CN102813931A Chitosan nanoparticles and their preparation method and use |
| 12/12/2012 | CN102813926A Application of miR-7 expression inhibitor in preparing medicines used for treating systemic lupus erythematosus |
| 12/12/2012 | CN102154482B Application of calcium activated chloride channels ANO1/TMEM16A in diagnosis and treatment of prostate cancer |
| 12/12/2012 | CN102140460B SiRNA (Small interference ribonucleic acid) as well as medicine composition and pharmaceutical application thereof |
| 12/12/2012 | CN101400366B Hepatitis c virus non structural fusion protein |
| 12/12/2012 | CN101203613B Method of increasing the function of gland related viral vector |
| 12/11/2012 | US8330026 Derivatives of the NF-κB inducing enzyme, their preparation and use |
| 12/11/2012 | US8329946 Histone deacetylases, and uses related thereto |
| 12/11/2012 | US8329945 Histone deacetylases, and uses related thereto |
| 12/11/2012 | US8329892 Methods and compositions for enhancing the efficacy and specificity of RNA silencing |
| 12/11/2012 | US8329890 SiRNA-mediated gene silencing |
| 12/11/2012 | US8329881 Metastatic colorectal cancer vaccine |
| 12/11/2012 | US8329671 Reduction of dermal scarring |
| 12/11/2012 | US8329670 System for delivering nucleic acids for suppressing target gene expression by utilizing endogenous chylomicron |
| 12/11/2012 | US8329667 Inhibition of hairless protein mRNA |